Abstracts tagged "SLE and utilization review"

Abstract Number: 188 • ACR/ARHP Annual Meeting 2017
Lupus Low Disease Activity State Is Associated with Reduced Direct Medical Costs in Patients with Systemic Lupus Erythematosus
Ai Li Yeo¹, Rachel Koelmeyer², Rangi Kandane-Rathnayake¹, Vera Golder², Alberta Y. Hoi², Edward R. Hammond³, Henk Nab⁴, Molla Huq⁵, Mandana Nikpour⁶ and Eric F Morand⁷, ¹Rheumatology, Monash University, Melbourne, Australia, ²Centre for Inflammatory Diseases, Monash University, Melbourne, Australia, ³AstraZeneca, Gaithersburg, MD, ⁴AstraZeneca, Cambridge, United Kingdom, ⁵Department of Medicine (Rheumatology), Melbourne University, Melbourne, Australia, ⁶Melbourne University, Melbourne, Australia, ⁷Monash University, Melbourne, Australia
Background/Purpose: High health care utilization and direct costs have been documented in multiple studies of SLE. The recently described lupus low disease activity state (LLDAS)…